CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 852 enrolled
Drug / intervention
Sleep apnea/hypopnea detectionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00766584
NCT00766584N/AActive
CompareCT.gov

Autonomic Nervous System Activity, Aging and Sleep Apnea/Hypopnea in a Prospective Cohort of Subjects Aged 67 Years

Centre Hospitalier Universitaire de Saint Etienne·observational·Posted Oct 6, 2008·Updated Mar 18, 2025

In Brief

An observational study evaluating Sleep apnea/hypopnea detection for Healthy. Active but no longer recruiting, targeting 852 participants across 1 site.

Detailed Summary

The regulatory effects of the autonomic nervous system (ANS) concern almost all organs which permanently feed information back to this global biological vigilance system controlling allostasis. Heart rate fluctuations are highly dependent on ANS control, making the heart one of the best indicators of ANS activity. Low ANS activity level is associated with severe cardiac and cerebral events, as well as to death from any cause in the general population. It is even associated with sleep apnea/hypopnea.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesFrance
CollaboratorsMinistry of Health, France

Timeline

N/AActive
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 6, 2008
Enrollment StartJan 15, 2003
Primary CompletionDec 1, 2026
TodayJul 2, 2026
Enrollment to primary: 23.9 yearsPosted 17.7 years agoPrimary completion in 5 months

Interventions

Sleep apnea/hypopnea detectionother

Simultaneous 24-hour ambulatory electrocardiogram and polygraphic recordings performed at home during a night.